India, March 31 -- What are your thoughts about the current trends and challenges facing the Indian clinical trials market? Where does India stand when we look at the global market?

India's clinical trials ecosystem is at a defining stage. Over the last few years, we have seen a clear transition from being perceived primarily as a cost-efficient execution market to becoming a more capable, quality-driven, and innovation-oriented research environment. Regulatory predictability has improved post New Drugs and Clinical Trial Rules (NDCT), 2019 and more digital tools are being integrated into trial design, and India is increasingly participating in complex and India relevant studies, including biologics and advanced therapies. Globally, Indi...